GNH USA

Europe — EMA

Nebinad (Nebivolol)

GNH USA supplies Nebinad (Nebivolol), a beta blocker for hypertension and heart failure. Request a quote for global supply to hospitals, pharmacies

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebinad, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure and certain forms of heart failure, helping to lower cardiovascular risk in adult patients.

GNH USA supplies Nebinad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

What is Nebivolol used for?

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular therapy.

- Hypertension: lowers systolic and diastolic blood pressure, reducing risk of stroke and myocardial infarction. - Chronic heart failure: improves left ventricular ejection fraction and reduces hospitalization rates in patients with reduced ejection fraction. - Post‑myocardial infarction: may help prevent recurrent cardiovascular events when used as part of standard therapy.

What are the side effects of Nebivolol?

Nebivolol may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Dizziness: especially upon standing, related to blood pressure lowering. - Fatigue: general tiredness reported during initial therapy. - Bradycardia: resting heart rate may fall below normal limits. - Nausea: occasional gastrointestinal discomfort. - Peripheral edema: mild swelling of lower extremities.

Serious or Rare Side Effects: - Severe bradycardia: heart rate markedly reduced, may require medical attention. - Atrioventricular block: conduction disturbances that can lead to syncope. - Bronchospasm: respiratory difficulty in patients with underlying airway disease. - Allergic reactions: rash, pruritus, or angioedema. - Hepatic dysfunction: abnormal liver enzymes indicating possible liver injury. - Hypotension: significant drop in blood pressure causing dizziness or fainting.

What precautions apply to Nebivolol?

Before initiating Nebinad, consider the following precautions: - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution; liver function tests are recommended. - Bradycardia: avoid in patients with resting heart rate below 60 bpm. - Asthma or COPD: beta‑blockade may exacerbate bronchospasm; assess respiratory status. - Pregnancy: safety not established; discuss risks with a healthcare professional. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

What does Nebivolol interact with?

Nebivolol can interact with several medicines; awareness of these interactions helps optimize safety.

Major Interactions (Avoid): - Other beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of atrioventricular block. - Clonidine abrupt withdrawal: may precipitate severe rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced hypotensive effect, monitor blood pressure. - Diuretics: potential electrolyte disturbances; assess serum electrolytes. - NSAIDs: may attenuate antihypertensive response, requiring dose adjustment.

Frequently asked questions

What is Nebinad used for?+
Nebinad contains nebivolol, a selective β1‑adrenergic blocker indicated for the treatment of essential hypertension and chronic heart failure with reduced ejection fraction. It helps lower blood pressure and improve cardiac function, thereby reducing the risk of cardiovascular complications in adult patients.
How does nebivolol work?+
Nebivolol works by selectively blocking β1‑adrenergic receptors in the heart, which reduces heart rate and contractile force, leading to lower cardiac output and blood pressure. Additionally, it enhances endothelial nitric oxide production, causing vasodilation that further contributes to its antihypertensive effect without significant β2‑receptor blockade.
What is the usual dose of Nebinad?+
The dose of Nebinad is individualized by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any comorbidities. Physicians determine the appropriate starting dose and any subsequent titration according to current treatment guidelines and patient tolerance.
Is nebivolol safe in pregnancy or breastfeeding?+
Safety data for nebivolol during pregnancy and lactation are limited, and the medication is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made in consultation with a qualified healthcare provider.
How do I order Nebinad from GNH USA?+
To order Nebinad, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.
How does nebivolol compare with other beta blockers?+
Nebivolol is distinguished by its high β1‑selectivity and additional nitric‑oxide‑mediated vasodilatory properties, which can result in fewer metabolic side effects compared with non‑selective beta blockers. While all beta blockers lower heart rate and blood pressure, nebivolol’s vasodilatory effect may offer better tolerability in some patients, especially those with peripheral vascular concerns.
How should Nebinad be stored and handled?+
Nebinad tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.
How is Nebinad administered?+
Nebinad is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Nebinad?+
Serious risks include severe bradycardia, atrioventricular block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare cases of hepatic dysfunction or allergic reactions. Patients should be monitored for symptoms such as fainting, chest discomfort, difficulty breathing, or unusual skin reactions and seek immediate medical attention if they occur.
Who should not use Nebinad?+
Nebinad is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia (resting heart rate < 60 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals with uncompensated heart failure or cardiogenic shock. Caution is also advised for patients with severe hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Recordati Polska Sp. Z O.O.
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA